Sanaluz

Sanaluz is a biotechnology company focused on developing advanced light-activated therapies for the treatment of cancer and infectious diseases. The company's core technology utilizes specific wavelengths of light to activate non-toxic photosensitizing agents, which then produce reactive oxygen species to selectively destroy targeted cells. This approach, known as photodynamic therapy (PDT), aims to provide a minimally invasive alternative to traditional surgery and chemotherapy with fewer systemic side effects. Sanaluz is currently advancing its platform through pre-clinical research to optimize light delivery systems and photosensitizer efficacy. Their mission is to harness the power of light to improve patient outcomes in oncology and beyond.